NEW YORK (GenomeWeb) – Although it didn't reach the 39 percent surge it saw in 2017, the GenomeWeb Index rose 13 percent in 2018 — vastly outperforming the broader markets, which have been rocked hard in the past several months by trade wars, general economic uncertainty, and, most recently, the US government shutdown.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers are refining a tool to predict a woman's risk of developing breast cancer, according to the Guardian.

According to Stat News, the partial government shutdown in the US could soon affect the ability of the Food and Drug Administration to review new drugs.

In PNAS this week: gypsy moth genome sequenced, phylogenomic analysis of Polyneopterans, and more.

CNN reports that people's genes tend to have a greater influence on their risk of developing disease than their environment, but it varies by phenotype.